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Thehumancoronaviruses(HCoVs)HCoV-NL63andHCoV-HKU1aretworecentlydiscoveredcoronavirusesthatcirculatewidely
and are associated with acute respiratory infections (ARI). We detected HCoV-NL63 and HCoV-HKU1 in specimens collected
fromMay2008toMarch2010frompatientswithARIaged<7.75yearsofageattendingtheBeijingChildren’sHospital.Thirty-two
(8.4%)and57(14.9%)of382specimenstestedpositiveforHCoV-NL63andHCoV-HKU1,respectively,byreal-timeRT-PCR.Use
of a Luminex xTAG RVP Fast kit showed that coinfection with respiratory syncytial virus and parainﬂuenza 3 virus was common
amongpatientsinfectedwitheithervirustype.InHCoV-HKU1-infectedpatients,thepredominantclinicalsymptomswerecough,
fever, and expectoration. In HCoV-NL63-infected patients they were cough, fever, and rhinorrhea. Phylogenetic studies showed
that the HCoV-HKU1 nucleoprotein gene was relatively conserved compared to NCBI reference sequences, while the 1ab gene of
HCoV-NL63 showed more variation.
1.Introduction
Before the outbreak of severe acute respiratory syndrome
caused by the SARS coronavirus in 2003, human coron-
aviruses (HCoVs) had not been considered harmful respi-
ratory pathogens. The outbreak of SARS renewed interest
in this virus family and resulted in the identiﬁcation of two
additional HCoVs, HCoV-NL63 and HCoV-HKU1. HCoV-
NL63, a member of the group I coronaviruses, was ﬁrst
detected in a child with bronchiolitis in The Netherlands
in 2004 [1]. HCoV-HKU1, a group II virus, was detected
in an adult with chronic pulmonary disease in Hong Kong
in 2005 [2]. It is now recognized that both these viruses
have a worldwide circulation and are associated with human
respiratory tract infections. In China, several groups have
demonstrated the existence of HCoV-NL63 and HCoV-
HKU1 as potential respiratory pathogens of infants and
the elderly [3–5]. However, more precise data regarding
their epidemiology, and genetic characteristics is lacking
in mainland China. In this study, we screened for the
presence of HCoV-NL63 and HCoV-HKU1 in children with
acute respiratory infection admitted to the Beijing Children’s
Hospital in an eﬀort to gain a better understanding of
the seasonality, epidemiology and genetic diversity of these
viruses in a city with a population of more than 22 million.
2.MaterialsandMethods
2.1. Clinical Specimens. A total of 382 nasopharyngeal
aspirates (NPAs) were collected from hospitalised children
with a diagnosis of pneumonitis or bronchopneumonia
and a body temperature above 38◦C. The children were
admitted to the Beijing Children’s Hospital between May
2008andMarch2010(a23-monthperiod).Theparentsofall
childreninvolvedinthestudyprovidedinformedconsentfor
specimen collection and testing. The children had a median
age of 1.1 years (range 1 month to 7.75 years). NPAs were
collected into virus transport medium and stored at −70◦C
before being tested.2 Advances in Virology
2.2. RNA Extraction and cDNA Synthesis. Nucleic acid was
extracted using QIAamp MinElute Virus Spin kits (Qiagen,
Mississauga, Ontario, Canada) according to the manufac-
turer’s instructions. cDNA was synthesized from 10µLo f
RNA eluate using random hexamer primers (TaKaRa Dalian,
China) and SuperScript II Reverse Transcriptase (Invitrogen
Carlsbad, Calif, USA).
2.3. Real-Time RT-PCR Assays.Two real-time RT-PCR assays
targeting conserved regions of the N and 1ab genes of both
viruses were developed and used in parallel. The primer and
probe sequences for HCoV-NL63 were as follows: NL63-
Nf o r w a r dp r i m e r5  -AGGACCTTAAATTCAGACAAC-
GTTCT-3 ; reverse primer 5 -GATTACGTTTGCGAT-
TACCAAGACT-3  [6]; TaqMan probe 5 -FAM-TAACAG-
TTTTAGCACCTTCCTTAGCAACCCAAACA-TAMRA-3 .
NL63-1ab forward primer 5 -TGTTGTAGTAGGTGGTTG-
TGTAACATCT-3 ; reverse primer 5 -AATTTTTGTGCA-
CCAGTATCAAGTTT-3 ;T a q M a np r o b e5  -FAM-CAA-
TTGTTAGTGAGAAAATTTCTGTTATGGA-TAMRA -3 
[7].
The primers and probes for HCoV-HKU1 were as fol-
lows: HKU-1-N forward primer 5 -AGTTCCCATTGCTTT-
CGGAGTA-3 ; reverse primer 5 -CCGGCTGTGTCTATA-
CCAATATCC-3 ;T a q M a n - M G Bp r o b e ,5  -FAM-CCCCTT-
CTGAAGCAA-MGB-3  [8]; HKU-1-1ab forward primer
5 -CCATTACAAGCCATAAGAGAACAAAC-3 ;r e v e r s e
primer 5 -TATGTGTGGCGGTTGCTATTATGT-3 ;T a q -
Man probe 5 -FAM-TTGCATCACCACTGCTAGTACCAC-
CAGG-TAMRA-3  [9].
To assess the sensitivity of the real-time RT-PCR assays,
amplicons of the N and 1ab genes were cloned into pET-9a
(QIAGEN) and pGEM-T Easy (Promega Corporation, USA)
vectors, respectively, followed by in vitro transcription using
the T7 RiboMAX Express Large Scale RNA Production
System (Promega). Standard curves for the N and 1ab gene
assays were constructed using serial log dilutions (from
101 to 107 copies) of the transcribed RNA fragments. The
lower limit of detection of each real-time RT PCR assay was
100 copies/20µL, with intra-assay coeﬃcients of variability
(CVs) between 0.45 and 1.02% (n = 3) and interassay CVs
between 0.68 and 2.24%.
2.4. Detection of HCoV-NL63 and HCoV-HKU1 in Clinical
Specimens. Specimens were tested for presence of HCoV-
NL63 orHCoV-HKU1 by real-time RT-PCRusing a TaqMan
RNA-to-CT 1-Step kit (Applied Biosystems, USA) and an
ABI Prism 7000 TaqMan machine (Applied Biosystems,
USA). 104 copies of N gene and 1ab gene transcripts were
used as positive controls in each run. The ampliﬁcation
conditions were 48◦C for 15min, followed by 40 cycles of
94◦C for 15sec and 60◦C for 15sec. For each virus, when
the CT value generated was less than 38, the specimen was
considered positive. When the CT value were relatively high
(38≤CT <40), the specimen was retested twice and consid-
ered positive if the CT v a l u eo fa n yr e t e s tw a sl e s st h a n4 0 .
2.5. Detection of Common Respiratory Viruses. All HCoV-
NL63- and HCoV-HKU1-positive samples were tested for
Table 1: HCoV-NL63 and HCoV-HKU1 detection in 382 children
with acute respiratory infections in Beijing, China, May 2008 to
March 2010. Age, gender, and clinical details are listed for those
positive for either virus.
Parameter
No. events detected in 382 children
tested (%)
NL63 (n = 32) HKU1 (n = 57)
Age (months)
≤12 21 (65.63) 44 (77.19)
12–35 10 (31.25) 13 (22.81)
36–93 1 (3.13) 0
Gender
Male 21 (65.63) 43 (75.4)
Female 11 (34.37) 14 (24.6)
Clinical symptoms
Cough 31(96.89) 56(98.25)
Fever 24(75.00) 36(63.16)
Rhinorrhea 9(28.13) 18 (31.58)
Expectoration 8 (25.00) 31(54.39)
Dyspnea 4 (12.50) 8 (14.04)
Nasal obstruction 2 (6.25) 9 (15.79)
Sore throat 3 (9.38) 2 (3.51)
Wheeze 0 2 (3.51)
Admitting diagnosis
Bronchopneumonia 10 (31.25) 18 (31.58)
Pneumonia 16 (50.00) 29 (50.88)
Bronchitis 4 (12.50) 5 (8.77)
Peribronchitis 1 (3.13) 3 (5.26)
Uncertainty 1 (3.13) 2 (3.51)
other respiratory viruses using luminex xTAG RVP Fast test
(Luminex Trading, Shanghai, China) on a Biorad Bio-Plex
200 (BioRad, Hercules, Calif, USA) suspension array system.
2.6. Phylogenetic Analysis.Fifteen sequences (251 nucleotides
(nt)) of the HCoV-NL63 replicase polyprotein 1ab gene and
ﬁve sequences (951nt) of the HCoV-HKU1 nucleoprotein
(N) gene were derived from positive samples using conven-
tional PCR and sequencing and subjected to phylogenetic
analysis.Genbanksequenceswiththehighestidentity(lowest
expect (E) value) in blastn searching were used as refer-
ences for this analysis, together with common type strain
HCoV sequences. Nt sequences AY597011.2, AY56787.2 and
DQ415910.1 were used as references for the HCoV-NL63
analysis. Sequences AY567487.2, AY518894.1, DQ445911.1,
GU068568.1, DQ846901.1, and EF081296.1 were applied in
the HCoV-HKU1 analysis. AF304460, representing the seq-
uence of HCoV-229E, was also included. Multiple sequence
alignment was performed with clustalW. Phylogenetic trees
were constructed using Neighbor-Joining. Bootstrap values
were calculated on 1000 replicates of the aligned data sets.Advances in Virology 3
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Figure 1: Temporal distribution of HCoV-NL63 and HCoV-HKU1 infections in hospitalized children between May 2008 and March 2010.
(a) the number of specimens collected from children admitted with acute respiratory infections to the Beijing Children’s Hospital; (b) the
number of positive specimens and percentage positive by month for HCoV-NL63; (c) the number of positive specimens and percentage
positive by month for HCoV-HKU1.
3. Results
3.1. Incidence and Clinical Symptoms Associated with HCoV-
NL63 and HCoV-HKU1 Infections in Hospitalized Children.
Of the 382 specimens tested, 32 (8.4%) were positive for
HCoV-NL63 and 57 (14.9%) were positive for HCoV-
HKU1. Testing and clinical data for patients with these
infections is summarized in Table 1. Most patients infected
with either HCoV-NL63 (65.6%) or HCoV-HKU1 (77.2%)
were less than 1 year of age at the time of investigation. Both
viruses were more frequently detected in males (Table 1).
The 4 most frequent clinical symptoms for both viruses
were cough, fever, rhinorrhea, and expectoration. However,
expectoration was a more frequent symptom in HCoV-
HKU1-infected patients (54.4 versus 25.0%). The admitting
diagnosis in more than 80% of children was pneumonia and
bronchopneumonia, irrespective of whether the infecting
virus was HCoV-NL63 or HCoV-HKU1.
3.2. Epidemiology of HCoV-NL63 and HCoV-HKU1 Infec-
tions. TheseasonaldistributionsofHCoV-NL63andHCoV-
HKU1 from May 2008 to the end of March 2010 were4 Advances in Virology
Table 2: Coinfection of HCoV-positive samples with other respiratory viruses.
Respiratory viruses No. coinfection of other respiratory viruses
HCoV-HKU1 positive, n (%)n = 57 HCoV-NL63 positive (%) n = 32
HCoV-HKU1 57 (100.00) 11 (34.38)
HCoV-NL63 11 (19.30) 32 (100.00)
HCoV-OC43 2 (3.51) 2 (6.25)
HCoV-229E 1 (1.75) 0 (0.00)
Inﬂuenza A 4 (7.02) 4 (12.50)
RSV 19 (33.33) 9 (28.13)
Parainﬂuenza 1 4 (7.02) 2 (6.25)
Parainﬂuenza 2 0 (0.00) 0 (0.00)
Parainﬂuenza 3 15 (26.32) 6 (18.75)
Parainﬂuenza 4 0 (0.00) 1 (3.13)
Adenovirus 0 (0.00) 3 (9.38)
Human metapneumovirus (hMPV) 7 (12.28) 5 (15.63)
None∗ 13 (14.04) 8 (25.00)
∗No other virus was detected in this test.
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Figure 2: Phylogenetic analysis of the nt sequences of HCoV-HKU1 (a) and HCoV-NL63 (b). The N genes were ampliﬁed from positive
samples collected between November 2008 and October 2009. Trees were constructed using Neighbor-Joining methods. Local HCoV strains
are indicated by the designation BJ and are all from 2009. Bootstrap values are indicated.Advances in Virology 5
similar, with heightened activity occurring at times when the
number of samples collected from children with respiratory
infections was declining (Figure 1). Peak incidences of both
viruses occurred in the summer of 2009 but not in 2008.
Increased HCoV-NL63 infections were also detected in the
fallandwintermonthsof2009,incontrastto2008whenonly
a small number of cases were recognized in winter. A similar
distribution occurred for HCoV-HKU1.
3.3. Coinfection of HCoV-NL63 and HCoV-HKU1 with Other
Respiratory Viruses. Testing of HCoV-positive samples using
a Luminex xTAG RVP Fast system revealed that many were
coinfected with other common respiratory viruses (Table 2),
in particular respiratory syncytial virus (RSV) and parain-
ﬂuenza virus type 3. Coinfections involving multiple HCoVs
were also detected (Table 2). Only 13 of 57 (14.0%) HCoV-
HKU1-positive patients and 8 of 32 (25%) HCoV-NL63-
positive patients tested negative for other respiratory viruses.
3.4. Phylogenetic Analysis of HCoV-NL63 and HCoV-HKU1
Strains. The results of phylogenetic analyses are shown
in Figure 2. Based on N gene analysis, the HCoV-HKU1
strains clustered together with the reference strain sequence
AY597011.1(Figure 2(a)),althoughthenumberofsequences
derived from clinical material and controls used in the
analysis was low. The 15 strains of HCoV-NL63 were more
widely distributed on the tree when the 1ab (replicase)
sequence was analysed (Figure 2(b)). Although shown to be
an HCoV-NL63 strain by PCR, BJET72 was not related to
any reference NL63 genes used in the analysis. The other 14
strains clustered into at least 3 distinct monophyletic groups,
one related to EF081296.1 and DQ846901.1, both originally
detected in the USA and China in 2007, a second close to
AY518894.1, a genotype A strain found in The Netherlands,
and a third close to GU068568, also detected in China in
2007. Possible evidence of subclustering within the group 2
sequences could be seen.
4. Discussion
Infection with HCoV-NL63 and HCoV-HKU1 has been
well documented in children presenting with respiratory
tract infections, although the epidemiology and clinical
course of these recently identiﬁed viruses have not been
fully elucidated in China. Our data indicate that HCoV-
NL63 and HCoV-HKU1 are present in hospitalized children
in Beijing and cause signiﬁcant morbidity. Several groups
have reported that these viruses can be detected in patients
with acute respiratory tract infections [10], including among
Chinese children and adults living in Hong Kong [3, 4]. We
found that HCoV-NL63 and HCoV-HKU1 were present in
8.4% and 14.9%, respectively, of respiratory samples col-
lectedovera23-monthperiod.Thisdetectionratewashigher
than that in previous reports from Hong Kong and other
countries [11–16], probably due to the increased detection
sensitivity of real-time RT-PCR technologies targeting the N
and 1ab genes.
Intemperateclimates,mostHCoV-NL63infectionsseem
to occur in winter and early spring, including in Canada
[6, 17]a n dF r a n c e[ 18]. In Hong Kong, most HCoV-NL63
infections were detected in the spring and summer of 2002,
in the early summer and autumn of 2004–2005, and in the
autumns of 2005-2007 [19]. In the present study, HCoV-
NL63 infections peaked in the summer, fall, and winter
months of 2009, but there was little activity at any time
during 2008. Similarly, HCoV-HKU1-positive specimens
were found frequently in winter-spring season in countries
with temperate climates, including the USA and Italy [20–
22].OurdatasuggeststhattheseasonalcirculationofHCoV-
NL63 and HCoV-HKU1 in temperate regions is dissimilar
to that occurring in the tropics. It is worthwhile noting
that more specimens from patients with ARI were collected
during the winter months of 2008 to spring months of 2009
than at any other time during the study, but the infection
rates of both viruses were relatively low during this time.
Being RNA viruses, HCoV-NL63 and HCoV-HKU1 have
a high degree of genetic diversity, although studies on the
sequence variability of HCoV-NL63 isolates in Asian coun-
tries are limited. Our N gene sequencing showed that HCoV-
HKU1 strains circulating in Beijing are genotype A viruses,
although the numbers analysed were small. The 1ab gene of
HCoV-NL63 viruses showed more diversity. However, fur-
thersequencingofothergenesisneededtoenableassessment
of the overall genetic diversity of HCoV-NL63 in Beijing and
to conﬁrm the genotype-speciﬁc assignment for these vir-
uses, since this depends on the gene sequence analyzed [23].
Studies of multiple respiratory viruses indicate that alt-
hough single infections with HCoVs occur, coinfection with
RSV and parainﬂuenza 3 viruses is common in both HCoV-
HKU1- and HCoV-NL63-positive patients. This makes it
diﬃcult to clarify the role of coronaviruses in childhood
pneumonia or bronchopneumonia. Future studies using
real-time RT-PCR and sample collection over several consec-
utive years will be helpful in providing further insights into
these etiologic agents of respiratory disease in China.
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